{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:58Z","timestamp":1787071018309,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Bladder cancer is one of the most common malignancies worldwide. Some studies noted sex differences in the prognosis of bladder cancer, but results are inconsistent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>\n                      In this study, we assessed whether women with bladder cancer exhibit a worse prognosis, after adjustment for disease stage, age, and body mass index (BMI), using clinical data from The Cancer Genome Atlas. We used a Student's\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test to compare age and BMI in groups with different sexes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>The Kaplan\u2013Meier method with log-rank test was used to determine clinical prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The BMI (30.15 vs. 26.68,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0035) and age (67.54 years vs. 66.01 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.045) of female patients with muscle-invasive bladder cancer (MIBC) were higher than those of male patients. The overall survival (OS) prognosis of female patients was worse than that of male patients. After grouping by disease characteristics, the disease-free survival (DFS) and OS prognoses of female patients under 60 years of age were worse than those of male patients. In the group with BMI &gt;24, the OS prognosis of female patients was worse than that of male patients, but no difference was found in DFS prognosis. In the group with BMI \u226424, the DFS prognosis of female patients was worse than that of male patients, but no difference was found in OS prognosis. Compared to males, female patients with Stage III disease demonstrated a worse DFS prognosis and poorer OS prognosis, women with stage T3 demonstrated a worse DFS prognosis, and women with stage N0 demonstrated a poorer OS prognosis. No difference was found in prognosis between male and female patients in all other groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In patients with MIBC, women tended to exhibit a worse prognosis than men. More specifically, we found a correlation between prognosis and sex after grouping patients by BMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_875_21","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T06:59:55Z","timestamp":1679900395000},"page":"1241-1247","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The impact of patient sex on characteristic-adjusted bladder cancer prognosis"],"prefix":"10.4103","volume":"17","author":[{"given":"Chunchun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caibin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20241021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R2-13-20241021","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.eururo.2017.06.022","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma: A step closer to clinical translation?","volume":"72","author":"Rentsch","year":"2017","journal-title":"Eur Urol"},{"key":"R3-13-20241021","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"R4-13-20241021","doi-asserted-by":"crossref","first-page":"e13981","DOI":"10.14814\/phy2.13981","article-title":"Cigarette smoking promotes bladder cancer via increased platelet -activating factor","volume":"7","author":"Kispert","year":"2019","journal-title":"Physiol Rep"},{"key":"R5-13-20241021","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"R6-13-20241021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.euf.2017.08.007","article-title":"Gender-specific differences in recurrence of non-muscle-invasive bladder cancer: A systematic review and meta-analysis","volume":"4","author":"Uhlig","year":"2018","journal-title":"Eur Urol Focus"},{"key":"R7-13-20241021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2018.03.001","article-title":"Bladder cancer survival: Women better off in the long run","volume":"95","author":"Andreassen","year":"2018","journal-title":"Eur J Cancer"},{"key":"R8-13-20241021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/tau.2018.11.06","article-title":"Review on gender differences in non-muscle invasive bladder cancer","volume":"8","author":"Bilski","year":"2019","journal-title":"Transl Androl Urol"},{"key":"R9-13-20241021","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12885-019-5924-6","article-title":"Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: A systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"key":"R10-13-20241021","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.euf.2016.05.005","article-title":"Functional outcomes following radical cystectomy in women with bladder cancer: A systematic review","volume":"3","author":"Smith","year":"2017","journal-title":"Eur Urol Focus"},{"key":"R11-13-20241021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clgc.2019.10.020","article-title":"Sex differences in urothelial bladder cancer survival","volume":"18","author":"Radkiewicz","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"R12-13-20241021","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejso.2014.03.003","article-title":"Gender-specific outcomes of bladder cancer patients: A stage-specific analysis in a contemporary, homogenous radical cystectomy cohort","volume":"41","author":"Soave","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"R13-13-20241021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.juro.2017.11.150","article-title":"Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: A systematic review and meta-analysis","volume":"200","author":"Uhlig","year":"2018","journal-title":"J Urol"},{"key":"R14-13-20241021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.juro.2009.08.145","article-title":"Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: A retrospective international study of 583 patients","volume":"183","author":"Tilki","year":"2010","journal-title":"J Urol"},{"key":"R15-13-20241021","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.urolonc.2011.09.011","article-title":"Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a","volume":"31","author":"May","year":"2013","journal-title":"Urol Oncol"},{"key":"R16-13-20241021","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00345-013-1232-y","article-title":"Gender-specific survival following radical cystectomy for pT4 bladder cancer","volume":"32","author":"Kaushik","year":"2014","journal-title":"World J Urol"},{"key":"R17-13-20241021","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"R18-13-20241021","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.eururo.2018.06.024","article-title":"Treatment strategy for newly diagnosed T1 high-grade bladder urothelial carcinoma: New insights and updated recommendations","volume":"74","author":"Klaassen","year":"2018","journal-title":"Eur Urol"},{"key":"R19-13-20241021","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bjc.2013.106","article-title":"Competing mortality in patients diagnosed with bladder cancer: Evidence of undertreatment in the elderly and female patients","volume":"108","author":"Noon","year":"2013","journal-title":"Br J Cancer"},{"key":"R20-13-20241021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/tau.2018.09.11","article-title":"Epidemiology, aetiology and screening of bladder cancer","volume":"8","author":"Cumberbatch","year":"2019","journal-title":"Transl Androl Urol"},{"key":"R21-13-20241021","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ecc.12217","article-title":"Conservative management and female gender are associated with increased cancer-specific death in patients with isolated primary urothelial carcinoma in situ","volume":"24","author":"Alanee","year":"2015","journal-title":"Eur J Cancer Care (Engl"},{"key":"R22-13-20241021","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/14737140.2020.1813029","article-title":"Gender discrepancies in bladder cancer: Potential explanations","volume":"20","author":"Viswambaram","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"R23-13-20241021","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00345-012-0996-9","article-title":"Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder","volume":"31","author":"Kluth","year":"2013","journal-title":"World J Urol"},{"key":"R24-13-20241021","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1464-410X.2009.09137.x","article-title":"The effect of gender on response to bacillus Calmette-Gu\u00e9rin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder","volume":"106","author":"Boorjian","year":"2010","journal-title":"BJU Int"},{"key":"R25-13-20241021","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"R26-13-20241021","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: A meta-analysis of 15,215 patients","volume":"33","author":"Martin-Doyle","year":"2015","journal-title":"J Clin Oncol"},{"key":"R27-13-20241021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"R28-13-20241021","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: An update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_875_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:24Z","timestamp":1787067624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_875_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_875_21","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}